In this review article, we aim to elaborate on the molecular machinery underlying PF, in particular, to emphasize the role of the AIM2 inflammasome in controlling PF, providing possible insights into AIM2-mediated therapy for this disease. The gene discussed is AIM2; the disease is pemphigus foliaceus.